Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Author index

Page Path

HOME
BROWSE ARTICLES
Author index

Author is indexed since 2010

Author :

Review

Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future

Tina Reinson, Ryan M. Buchanan, Christopher D. Byrne

Clin Mol Hepatol. 2023;29(Suppl):S157-S170. Published online November 22, 2022

DOI: https://doi.org/10.3350/cmh.2022.0348

View: 6718 Download: 354 Web of Science: 31 Crossref: 31

Tina Reinson

1 Articles

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

MOST VIEWED (Last 6 months)

Viewed By 12590	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7645	Radiogenomics of intrahepatic cholangiocarcinoma predicts immunochemotherapy response and identifies therapeutic target
Viewed By 7133	MAFLD: How is it different from NAFLD?
Viewed By 5686	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 5616	Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment

+more

MOST CITED (2023-2025)

Cited By 366	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 354	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 232	MAFLD: How is it different from NAFLD?
Cited By 122	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 116	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

+more

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051 FAX: +82-2-703-0071 E-mail: cmh_journal@ijpnc.com

COUNTER

TODAY : 6432

TOTAL : 2920486